Inhibrx Biosciences (INBX) Shareholder's Equity (2023 - 2025)
Inhibrx Biosciences (INBX) Shareholder's Equity (2023 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Inhibrx Biosciences |
186.16 Mn |
186.16 Mn |
- |
7.99 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
7.99 Mn |
| Sep 30, 2025 |
36.83 Mn |
| Jun 30, 2025 |
68.56 Mn |
| Mar 31, 2025 |
94.44 Mn |
| Dec 31, 2024 |
133.58 Mn |
| Sep 30, 2024 |
178.47 Mn |
| Jun 30, 2024 |
219.37 Mn |
| Mar 31, 2024 |
11.57 Mn |
| Dec 31, 2023 |
43.50 Mn |
| Sep 30, 2023 |
129.60 Mn |
| Jun 30, 2023 |
-24.81 Mn |
